Cargando…
The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
Approximately 3% of US adults are immunocompromised and less capable of fighting infections such as SARS-CoV-2 (the causative agent of COVID-19). Individuals may be immunocompromised for reasons related to an underlying medical condition or to immunomodulatory therapies that alter the immune respons...
Autores principales: | Antinori, Andrea, Bausch-Jurken, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401620/ https://www.ncbi.nlm.nih.gov/pubmed/37539764 http://dx.doi.org/10.1093/infdis/jiad181 |
Ejemplares similares
-
COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Rouphael, Nadine, et al.
Publicado: (2023) -
A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations
por: Bonanni, Paolo, et al.
Publicado: (2023) -
Foreword: Preventing COVID-19 Among the Immunocompromised Population
por: Willicombe, Michelle
Publicado: (2023) -
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Hall, Victoria G, et al.
Publicado: (2023) -
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases
por: Finckh, Axel, et al.
Publicado: (2023)